Related Experiment Video
Updated: Aug 3, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
The Influence of Simvastatin on NGAL, Matrix Metalloproteinases and Their Tissue Inhibitors in Human Intraluminal
A Piechota-Polanczyk1, S Demyanets2, M Mittlboeck3
1Department of Surgery, Division of Vascular Surgery, Medical University of Vienna, Waehringer Guertel 18-20, Vienna 1090, Austria.
Objective/Background:
Matrix metalloproteinases (MMPs) play a pivotal role in the development and progression of abdominal aortic aneurysms (AAAs). The action of MMPs depends on a balance between tissue inhibitors of MMPs (TIMPs) and compounds that may prolong protease activity, such as neutrophil gelatinase-associated lipocalin (NGAL).
Methods:
The study was designed to analyse gene expression and protein concentration of MMPs, TIMPs, and NGAL in AAA walls and intraluminal thrombi (ILTs) of patients on simvastatin (n = 10) and not on statins (n = 10). The patients were matched by age, sex, and AAA diameter. Expression of MMP2, MMP9, TIMP1, TIMP2, and NGAL was investigated by real time polymerase chain reaction, and MMP2, MMP9, MMP9/TIMP1, MMP9/TIMP2, and MMP9/NGAL protein levels by enzyme-linked immunosorbent assay.
Results:
MMP2 and MMP9 protein and mRNA levels were comparable in the simvastatin and non-statin groups (p > .05); however, there was a significant decrease in TIMP1 mRNA in AAA tissue (p = .04). Moreover, a significant increase in MMP9/TIMP2 complex concentration in ILTs of patients on simvastatin was noted (median 94.71 ng/mL in the simvastatin group vs. 36.80 ng/mL in the non-statin group; p = .01). No significant difference was observed for NGAL mRNA or protein content in AAA and ILT.
Conclusion:
Simvastatin treatment in patients with AAAs may influence the concentration of proteases and their inhibitors (TIMPs) in aneurysmal wall tissue and ILTs. Thus, further studies should be undertaken to understand the different influence of statin therapy on the components of the MMP/TIMP system in AAAs and ILTs.
Insights
Simvastatin may alter matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) levels in abdominal aortic aneurysms (AAAs). Further research is needed to clarify statin therapy
Area of Science:
- Cardiovascular Biology
- Biochemistry
- Pharmacology
Background:
- Matrix metalloproteinases (MMPs) are crucial in abdominal aortic aneurysm (AAA) development.
- The balance between MMPs, tissue inhibitors of MMPs (TIMPs), and neutrophil gelatinase-associated lipocalin (NGAL) influences protease activity.
- Understanding these interactions is key to managing AAA progression.
Purpose of the Study:
- To investigate the impact of simvastatin on MMPs, TIMPs, and NGAL in AAA tissues.
- To compare gene expression and protein levels between patients on simvastatin and those not on statins.
Main Methods:
- Analysis of MMP2, MMP9, TIMP1, TIMP2, and NGAL gene expression via real-time PCR.
- Quantification of MMP2, MMP9, MMP9/TIMP1, MMP9/TIMP2, and MMP9/NGAL protein levels using ELISA.
- Patients were matched for age, sex, and AAA diameter.
Main Results:
- MMP2 and MMP9 levels (mRNA and protein) were similar between groups.
- A significant decrease in TIMP1 mRNA was observed in AAA tissue from patients on simvastatin.
- An increased concentration of the MMP9/TIMP2 complex was found in intraluminal thrombi (ILTs) of patients on simvastatin.
Conclusions:
- Simvastatin may modulate protease and inhibitor concentrations within AAA walls and ILTs.
- Further studies are warranted to elucidate the specific effects of statin therapy on the MMP/TIMP system in AAAs.
- These findings highlight potential therapeutic targets for AAA management.
More Related Videos
09:32Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model
Published on: February 23, 2020
07:05Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy
Published on: September 27, 2024